A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir
Clinical trial NCT02262715 · COMPLETED
Trial details
- NCT number
- NCT02262715
- Sponsor
- Janssen Infectious Diseases BVBA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-10-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.